Status:
COMPLETED
A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.
Lead Sponsor:
Seikagaku Corporation
Conditions:
Dry Eye Syndromes
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to assess the safety and effectiveness of SI-614 solution compared with placebo solution in treating patients with dry eye.
Eligibility Criteria
Inclusion
- Be at least 18 years of age
- Have provided written informed consent
- Have dry eye in both eyes
Exclusion
- Use of contact lenses
- Have an uncontrolled systemic disease
- Have an uncontrolled psychiatric condition, or substance or alcohol abuse
- Women who is pregnant, nursing or planning a pregnancy
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT02205840
Start Date
July 1 2014
Last Update
July 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Andover, Massachusetts, United States